Mental Health Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Legal Issues
Is GSK guilty of fraud?
June 28th, 2004
A newly published editorial calls on GlaxoSmithKline (GSK) to make all its research on paroxetine (Seroxat/Paxil) publicly available. This follows the filing of a lawsuit by the state of New York against GSK: The state accuses the company of fraud, by depriving consumers of the information they and their doctors need to make informed decisions about treatment, and seeks the return of all profits obtained through fraudulent means. The editorial was published in the June 12, 2004, issue of the Lancet. Paroxetine is not licensed for use by adolescents or children in the U.S. or Europe; however, "off-label" prescribing is not...
Source: Mental Health Weekly Digest (2004-06-28)
|
